Page last updated: 2024-09-04

cycloastragenol and Colitis, Ulcerative

cycloastragenol has been researched along with Colitis, Ulcerative in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Al-Gayyar, MMH; Almasri, D; Bagalagel, A; Bakhsh, HT; Diri, R; Kutbi, HI; Noor, A	1

Other Studies

1 other study(ies) available for cycloastragenol and Colitis, Ulcerative

Article	Year
The therapeutic effects of cycloastragenol in ulcerative colitis by modulating SphK/MIP-1α/miR-143 signalling. Basic & clinical pharmacology & toxicology, 2022, Volume: 131, Issue:5 Topics: Animals; bcl-2-Associated X Protein; Chemokine CCL3; Colitis, Ulcerative; Eosine Yellowish-(YS); Female; Male; MicroRNAs; NF-kappa B; Phosphotransferases (Alcohol Group Acceptor); Rats; Sapogenins; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha	2022

Article

Year

The therapeutic effects of cycloastragenol in ulcerative colitis by modulating SphK/MIP-1α/miR-143 signalling.

Basic & clinical pharmacology & toxicology, 2022, Volume: 131, Issue:5

Topics: Animals; bcl-2-Associated X Protein; Chemokine CCL3; Colitis, Ulcerative; Eosine Yellowish-(YS); Female; Male; MicroRNAs; NF-kappa B; Phosphotransferases (Alcohol Group Acceptor); Rats; Sapogenins; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha

2022